Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts.

M Fukushima; H Satake; J Uchida; Y Shimamoto; T Kato; T Takechi; H Okabe; A Fujioka; K Nakano; H Ohshimo

doi:10.3892/ijo.13.4.693

Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts.

Identifier:nobleid.org/w1/20260515/ACEB9705

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ACEB9705.svg?ark=w1%2F20260515%2FACEB9705)](https://nobleid.org/work/w1/20260515/ACEB9705)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts.

Identifier:nobleid.org/w1/20260515/ACEB9705

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ACEB9705.svg?ark=w1%2F20260515%2FACEB9705)](https://nobleid.org/work/w1/20260515/ACEB9705)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work